See more : Bryn Mawr Bank Corporation (BMTC) Income Statement Analysis – Financial Results
Complete financial analysis of Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Anhui Fengyuan Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Shenzhen InfoGem Technologies Co., Ltd. (300085.SZ) Income Statement Analysis – Financial Results
- Oriental Energy Co., Ltd. (002221.SZ) Income Statement Analysis – Financial Results
- Slam Exploration Ltd. (SLMXF) Income Statement Analysis – Financial Results
- ContraFect Corporation (CFRX) Income Statement Analysis – Financial Results
- Victory Supermarket Chain Ltd (VCTR.TA) Income Statement Analysis – Financial Results
Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ)
About Anhui Fengyuan Pharmaceutical Co., Ltd.
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells biological pharmacy, chemical pharmacy, and traditional Chinese medicines primarily in China. It offers antipyretic-analgesic, cardiovascular, antibiotic, nervous system, anti-tumor, antiulcer, and hormone drugs, as well as nutraceuticals. The company also provides general medicines for vitamin and mineral deficiency; medicines for resisting parasitic diseases and microorganisms; coenzymes; and antiviral and uterine contractive medicines. In addition, it offers sedative-hypnotic drugs; drugs for curing mesenteric stress syndrome; drugs for lowering blood pressure; and drugs for curing benign prostatic hyperplasia. The company also exports its products to Europe, North America, Africa, Southeast Asia, and Central Asia. Anhui Fengyuan Pharmaceutical Co., Ltd. was founded in 1997 and is based in Hefei, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.28B | 4.00B | 3.50B | 3.32B | 3.24B | 3.01B | 2.58B | 2.03B | 1.55B | 1.70B | 1.53B | 1.66B | 1.52B | 1.07B | 955.70M | 873.81M | 703.78M | 521.29M | 441.21M | 280.54M | 179.12M | 157.94M | 159.21M | 114.15M | 57.21M | 49.63M | 44.11M |
| Cost of Revenue | 3.18B | 2.87B | 2.45B | 2.17B | 2.00B | 1.84B | 1.79B | 1.49B | 1.14B | 1.25B | 1.13B | 1.28B | 1.21B | 788.84M | 693.49M | 640.25M | 527.86M | 392.28M | 328.78M | 205.68M | 110.20M | 85.99M | 80.66M | 69.49M | 35.61M | 31.49M | 28.21M |
| Gross Profit | 1.10B | 1.13B | 1.05B | 1.15B | 1.24B | 1.17B | 788.88M | 541.22M | 417.60M | 450.23M | 398.64M | 380.93M | 303.31M | 285.34M | 262.20M | 233.55M | 175.92M | 129.01M | 112.43M | 74.86M | 68.93M | 71.95M | 78.55M | 44.65M | 21.60M | 18.14M | 15.91M |
| Gross Profit Ratio | 25.71% | 28.23% | 30.11% | 34.66% | 38.16% | 38.95% | 30.60% | 26.61% | 26.87% | 26.50% | 26.06% | 22.98% | 20.00% | 26.56% | 27.44% | 26.73% | 25.00% | 24.75% | 25.48% | 26.69% | 38.48% | 45.56% | 49.34% | 39.12% | 37.76% | 36.56% | 36.05% |
| Research & Development | 75.01M | 65.47M | 70.06M | 75.47M | 77.96M | 72.88M | 59.67M | 29.69M | 27.79M | 26.37M | 24.33M | 20.70M | 22.86M | 25.14M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 33.98M | 34.27M | 36.18M | 35.76M | 44.79M | 30.87M | 32.02M | 53.63M | 32.14M | 34.32M | 29.11M | 28.51M | 24.01M | 20.19M | 76.53M | 70.39M | 48.25M | 47.15M | 43.38M | 35.00M | 30.03M | 23.87M | 26.92M | 7.77M | 6.32M | 5.02M | 5.20M |
| Selling & Marketing | 584.29M | 680.47M | 653.73M | 780.08M | 859.21M | 807.77M | 463.18M | 265.45M | 204.52M | 229.41M | 215.43M | 215.49M | 174.05M | 151.81M | 146.56M | 121.96M | 80.30M | 58.53M | 46.16M | 18.77M | 14.70M | 12.17M | 20.44M | 5.08M | 3.61M | 2.94M | 2.58M |
| SG&A | 618.27M | 714.75M | 689.91M | 815.84M | 904.00M | 838.63M | 495.21M | 319.08M | 236.65M | 263.73M | 244.54M | 244.00M | 198.06M | 172.01M | 223.09M | 192.34M | 128.55M | 105.68M | 89.54M | 53.77M | 44.74M | 36.04M | 47.36M | 12.84M | 9.93M | 7.96M | 7.79M |
| Other Expenses | 190.61M | 117.67M | 103.73M | 98.99M | 96.25M | 549.30K | 548.63K | 75.99M | 11.93M | 10.53M | 12.76M | 12.23M | 6.27M | 13.72M | 5.34M | 742.68K | 798.70K | 27.00M | 2.70M | 250.80K | 1.38M | 1.97M | 1.10M | 1.33M | 188.59K | 18.76K | 12.82K |
| Operating Expenses | 885.89M | 897.88M | 863.70M | 990.30M | 1.08B | 1.03B | 655.74M | 449.23M | 357.24M | 384.45M | 347.32M | 343.72M | 283.24M | 242.58M | 228.49M | 196.80M | 132.03M | 108.36M | 91.44M | 55.52M | 45.92M | 37.48M | 48.78M | 13.69M | 10.20M | 8.11M | 7.99M |
| Cost & Expenses | 4.06B | 3.77B | 3.31B | 3.16B | 3.08B | 2.87B | 2.44B | 1.94B | 1.49B | 1.63B | 1.48B | 1.62B | 1.50B | 1.03B | 921.98M | 837.06M | 659.89M | 500.64M | 420.22M | 261.20M | 156.12M | 123.47M | 129.44M | 83.19M | 45.80M | 39.60M | 36.20M |
| Interest Income | 8.71M | 5.36M | 3.11M | 3.71M | 3.86M | 4.05M | 2.51M | 2.18M | 2.06M | 2.89M | 3.00M | 646.20K | 474.49K | 910.74K | 3.53M | 1.28M | 1.62M | 3.94M | 1.86M | 3.17M | 4.45M | 3.01M | 5.07M | 1.78M | -0.83 | -0.33 | -0.89 |
| Interest Expense | 33.89M | 32.87M | 38.59M | 39.47M | 37.08M | 31.02M | 32.36M | 28.49M | 31.87M | 32.10M | 22.10M | 20.59M | 16.26M | 14.50M | 17.67M | 18.42M | 16.24M | 19.64M | 14.56M | 6.50M | 3.32M | 2.22M | 3.68M | 2.51M | 2.10M | 1.75M | 2.15M |
| Depreciation & Amortization | 139.15M | 133.18M | 126.25M | 87.05M | 81.09M | 80.93M | 78.71M | 71.27M | 63.24M | 68.76M | 58.84M | 52.42M | 50.24M | 49.56M | 44.75M | 41.22M | 39.30M | 30.07M | 32.13M | 27.76M | 23.44M | 15.20M | 9.43M | 5.52M | 3.72M | 2.29M | 2.42M |
| EBITDA | 388.67M | 371.21M | 328.08M | 270.67M | 243.09M | 209.63M | 209.03M | 167.60M | 140.62M | 157.25M | 122.09M | 100.83M | 82.00M | 117.75M | 96.03M | 80.23M | 71.36M | 87.88M | 58.56M | 50.49M | 53.35M | 51.09M | 44.73M | 34.52M | 15.13M | 10.04M | 7.91M |
| EBITDA Ratio | 9.09% | 9.02% | 7.75% | 7.73% | 7.18% | 7.20% | 8.41% | 12.05% | 9.26% | 9.33% | 8.30% | 6.37% | 5.30% | 12.49% | 9.66% | 9.77% | 11.17% | 16.80% | 13.27% | 17.86% | 29.78% | 32.35% | 28.14% | 34.07% | 26.75% | 20.22% | 17.94% |
| Operating Income | 213.25M | 202.10M | 146.03M | 185.87M | 124.11M | 92.55M | 96.14M | 62.87M | 30.23M | 45.91M | 28.53M | 14.57M | 7.89M | 39.61M | 26.92M | 19.86M | 15.03M | 12.43M | 11.17M | 16.53M | 24.11M | 31.70M | 30.59M | 29.53M | 8.59M | 7.75M | 5.49M |
| Operating Income Ratio | 4.99% | 5.05% | 4.17% | 5.60% | 3.83% | 3.07% | 3.73% | 3.09% | 1.94% | 2.70% | 1.86% | 0.88% | 0.52% | 3.69% | 2.82% | 2.27% | 2.14% | 2.38% | 2.53% | 5.89% | 13.46% | 20.07% | 19.21% | 25.87% | 15.02% | 15.62% | 12.46% |
| Total Other Income/Expenses | 1.64M | 194.66K | 3.16M | 7.56M | -4.16M | 549.30K | 548.63K | 3.69M | 8.05M | 10.48M | 12.62M | 10.71M | 6.17M | 12.96M | 5.19M | -16.16M | -28.08M | 25.41M | -11.13M | -4.44M | 2.49M | 1.97M | 1.10M | -3.04M | 188.59K | 18.76K | 12.83K |
| Income Before Tax | 214.89M | 202.29M | 149.73M | 138.11M | 119.94M | 93.09M | 96.69M | 66.56M | 42.07M | 56.39M | 41.15M | 25.28M | 13.79M | 52.57M | 32.12M | 20.59M | 15.81M | 37.84M | 11.87M | 15.84M | 26.59M | 33.68M | 31.69M | 30.86M | 8.78M | 7.77M | 5.51M |
| Income Before Tax Ratio | 5.03% | 5.05% | 4.28% | 4.16% | 3.70% | 3.09% | 3.75% | 3.27% | 2.71% | 3.32% | 2.69% | 1.53% | 0.91% | 4.89% | 3.36% | 2.36% | 2.25% | 7.26% | 2.69% | 5.65% | 14.85% | 21.32% | 19.90% | 27.03% | 15.35% | 15.65% | 12.48% |
| Income Tax Expense | 57.60M | 51.35M | 40.26M | 36.02M | 39.33M | 32.39M | 31.34M | 20.85M | 10.60M | 15.28M | 13.96M | 7.19M | 3.87M | 12.09M | 8.41M | 5.40M | 9.92M | 15.69M | 2.59M | 5.80M | 8.47M | 7.85M | 6.92M | 4.59M | 146.29K | 75.87K | 1.04M |
| Net Income | 159.29M | 154.43M | 122.98M | 103.72M | 80.92M | 60.93M | 65.35M | 45.84M | 32.39M | 40.99M | 27.35M | 19.02M | 9.91M | 41.63M | 22.99M | 14.18M | 5.63M | 22.01M | 9.03M | 9.59M | 18.12M | 25.82M | 24.77M | 26.27M | 8.64M | 7.69M | 4.47M |
| Net Income Ratio | 3.73% | 3.86% | 3.51% | 3.12% | 2.50% | 2.02% | 2.53% | 2.25% | 2.08% | 2.41% | 1.79% | 1.15% | 0.65% | 3.88% | 2.41% | 1.62% | 0.80% | 4.22% | 2.05% | 3.42% | 10.12% | 16.35% | 15.56% | 23.01% | 15.09% | 15.50% | 10.13% |
| EPS | 0.34 | 0.49 | 0.39 | 0.33 | 0.26 | 0.20 | 0.21 | 0.15 | 0.11 | 0.13 | 0.09 | 0.07 | 0.04 | 0.16 | 0.09 | 0.05 | 0.02 | 0.09 | 0.03 | 0.04 | 0.07 | 0.10 | 0.09 | 0.08 | 0.03 | 0.03 | 0.02 |
| EPS Diluted | 0.34 | 0.49 | 0.39 | 0.33 | 0.26 | 0.19 | 0.21 | 0.15 | 0.11 | 0.13 | 0.09 | 0.07 | 0.04 | 0.16 | 0.09 | 0.05 | 0.02 | 0.09 | 0.03 | 0.04 | 0.07 | 0.10 | 0.09 | 0.08 | 0.03 | 0.03 | 0.02 |
| Weighted Avg Shares Out | 464.97M | 317.16M | 312.14M | 312.14M | 312.14M | 312.14M | 312.14M | 312.14M | 312.14M | 312.19M | 299.20M | 260.18M | 259.90M | 260.00M | 255.40M | 283.67M | 259.65M | 269.31M | 281.72M | 281.72M | 281.72M | 281.72M | 281.72M | 281.72M | 281.72M | 281.72M | 281.72M |
| Weighted Avg Shares Out (Dil) | 464.97M | 317.16M | 312.14M | 312.14M | 312.14M | 317.16M | 312.52M | 312.24M | 312.15M | 312.19M | 299.20M | 260.18M | 259.90M | 260.00M | 255.40M | 283.67M | 259.65M | 269.31M | 281.72M | 281.72M | 281.72M | 281.72M | 281.72M | 281.72M | 281.72M | 281.72M | 281.72M |
Source: https://incomestatements.info
Category: Stock Reports